Thermo Fisher Scientific Inc (TMO) Shares Sold by United Services Automobile Association

United Services Automobile Association decreased its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 619,277 shares of the medical research company’s stock after selling 2,499 shares during the period. United Services Automobile Association owned about 0.16% of Thermo Fisher Scientific worth $95,121,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. Independent Portfolio Consultants Inc. boosted its position in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares in the last quarter. Sharkey Howes & Javer boosted its position in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares in the last quarter. Penserra Capital Management LLC boosted its position in Thermo Fisher Scientific by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,150 shares of the medical research company’s stock worth $176,000 after buying an additional 100 shares in the last quarter. South Texas Money Management Ltd. bought a new position in Thermo Fisher Scientific during the first quarter worth about $202,000. Finally, Cedar Wealth Management LLC boosted its position in Thermo Fisher Scientific by 3.7% in the first quarter. Cedar Wealth Management LLC now owns 1,473 shares of the medical research company’s stock worth $226,000 after buying an additional 53 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific Inc (TMO) traded up 0.21% on Friday, reaching $176.11. 606,231 shares of the company’s stock traded hands. The firm’s 50 day moving average price is $176.88 and its 200 day moving average price is $164.14. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $182.87. The company has a market cap of $68.68 billion, a PE ratio of 30.68 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period last year, the company earned $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, equities analysts expect that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: This piece was published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.themarketsdaily.com/2017/08/04/united-services-automobile-association-has-95-12-million-stake-in-thermo-fisher-scientific-inc-tmo-updated.html.

A number of research firms recently issued reports on TMO. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price objective for the company in a research report on Tuesday. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Saturday, June 10th. Barclays PLC reissued an “overweight” rating and set a $200.00 target price (up from $190.00) on shares of Thermo Fisher Scientific in a report on Monday, July 17th. Finally, Citigroup Inc. reissued a “buy” rating and set a $201.00 target price (up from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. One equities research analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. Thermo Fisher Scientific currently has a consensus rating of “Buy” and an average price target of $188.56.

In other news, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total value of $805,773.44. Following the sale, the insider now directly owns 29,200 shares of the company’s stock, valued at $5,018,896. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $176.26, for a total value of $440,650.00. Following the completion of the sale, the chief financial officer now directly owns 37,790 shares in the company, valued at $6,660,865.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,188 shares of company stock worth $4,702,223. 0.49% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

5 × three =